Balancing Innovation and Ethics: An Analysis of the Patenting of Human Genetic Material

The rapid growth of biotechnology, especially in the area of human genetics, has brought forth significant scientific progress while also raising serious ethical and legal concerns. Developments such as genetic engineering and CRISPR gene editing have expanded the limits of traditional patent systems, particularly when it comes to determining whether human genetic material qualifies as an invention. This phenomenon creates a continuous conflict between promoting innovation and protecting fundamental ethical values. This paper examines how Indian patent law aims to maintain this balance. It analyses the key legal provisions and judicial interpretations that restrict the patenting of naturally occurring genetic material, while still recognising the possibility for scientific advancement. In order to understand India’s position, the paper compares it with the approaches that are being followed in the United States and the European Union, where the courts have taken different views on the patentability of genetic material. The paper uses a qualitative research method, where it analyses the relevant literature, case laws and statutory frameworks to identify the existing gaps and challenges that can arise in this area of study. It focuses on important issues such as the difference between discovery and invention, the ethical concerns surrounding the commercialisation of human biology, and the broader impact it has on the access to healthcare and research. Overall, this paper highlights the importance of establishing a more balanced and ethically conscious patent framework. The paper argues that while innovation is important and should be encouraged, it should not come at the cost of human dignity or the larger public interest.